Author

S. R. Kaushik

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1

Frequent Co-Authors

R. Arya· 3 shared R. Nanda· 3 shared O. Shriwas· 2 shared R. Dash· 2 shared R. Rath· 2 shared S. Mohanty· 2 shared S. Sahu· 2 shared A. Gupta· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

R. Arya

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Deferoxamine as adjunct therapeutics for tuberculosis

S. R. Kaushik, N. Yadav, A. Gupta, S. Sahu, N. Bhalla, P. Dagar, A. K. Mohapatra, A. Sarangi, T. Sharma, B. Biswal, A. K. Pandey, R. Nanda

This study shows Deferoxamine (DFO) has antimycobacterial properties and can reduce Mtb burden when used as an adjunct to standard tuberculosis treatments.

bioRxiv · Jun 2, 2023 · PreprintMicrobiology

Troxerutin acts on complement mediated inflammation to ameliorate arthritic symptoms in rats.

D. Sahu, S. C. Biswal, M. Z. Malik, S. Sahu, S. R. Kaushik, S. Sharma, E. Saini, R. Arya, A. Rastogi, S. Sharma, S. Sen, R. K. B. Singh, R. Nanda, A. K. Panda

This study shows that troxerutin reduces arthritis symptoms in rats by modulating complement-mediated inflammation.

bioRxiv · Aug 18, 2020 · PreprintBiochemistry

CMTM6 drives cisplatin resistance in OSCC by regulating AKT mediated Wnt signaling

P. Mohapatra, O. Shriwas, S. Mohanty, S. R. Kaushik, R. Arya, R. Rath, S. Das Majumdar, D. Muduly, R. K. Nanda, R. Dash

This study identifies CMTM6 as a driver of cisplatin resistance in OSCC by activating AKT-mediated Wnt signaling, leading to increased survival gene expression and tumor growth.

bioRxiv · Mar 18, 2020Cancer Biology

RRBP1 rewires cisplatin resistance in Oral Squamous Cell Carcinoma by regulating YAP-1

O. Shriwas, R. Arya, S. Mohanty, S. Kumar, R. Rath, S. R. Kaushik, M. C. Thakur, F. Pahwa, S. K. D. Majumdar, D. K. Muduly, R. Nanda, R. Dash

This study identifies RRBP1 as a key regulator of cisplatin resistance in OSCC, showing its role in YAP-1 regulation and demonstrating that Radezolid can restore cisplatin sensitivity.

bioRxiv · Mar 18, 2020Cancer Biology